BioCatalyst

IMU-838 tablets — catalyst calendar

2 verified catalyst event(s) referencing IMU-838 tablets, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 4mo
ESTIMATED
 READOUT
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients
Phase 3 · Multiple Sclerosis
 IMUX IMMUNIC, INC. IMU-838 tablets ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-11 (month)
in 4mo
ESTIMATED
 READOUT
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients W
Phase 3 · Multiple Sclerosis, Relapsing-Remitting
 IMUX IMMUNIC, INC. IMU-838 tablets ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.